abstract |
(57) [Summary]nThe present invention relates to a pharmaceutical composition comprising an inhibitor of at least one lipase and a fatty acid ester of at least one polyol, wherein the fatty acid ester has a melting point above body temperature, and the polyol is a sugar, a sugar derivative and these The pharmaceutical composition is selected from the group consisting of a mixture. |